CervoMed Statistics Share Statistics CervoMed has 8.7M
shares outstanding. The number of shares has increased by 5.44%
in one year.
Shares Outstanding 8.7M Shares Change (YoY) 5.44% Shares Change (QoQ) 0% Owned by Institutions (%) 26.24% Shares Floating 5.64M Failed to Deliver (FTD) Shares 1,683 FTD / Avg. Volume 0.45%
Short Selling Information The latest short interest is 109.92K, so 1.26% of the outstanding
shares have been sold short.
Short Interest 109.92K Short % of Shares Out 1.26% Short % of Float 1.9% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.16 and the forward
PE ratio is -5.14.
CervoMed's PEG ratio is
-0.01.
PE Ratio -1.16 Forward PE -5.14 PS Ratio 1.94 Forward PS 7.2 PB Ratio 0.48 P/FCF Ratio -1.14 PEG Ratio -0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for CervoMed.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 11.11,
with a Debt / Equity ratio of 0.
Current Ratio 11.11 Quick Ratio 11.11 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $649.2K Profits Per Employee $-1.09M Employee Count 15 Asset Turnover 0.23 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -21.43% in the
last 52 weeks. The beta is -0.8, so CervoMed's
price volatility has been lower than the market average.
Beta -0.8 52-Week Price Change -21.43% 50-Day Moving Average 7.58 200-Day Moving Average 7.04 Relative Strength Index (RSI) 65.44 Average Volume (20 Days) 374,437
Income Statement In the last 12 months, CervoMed had revenue of 9.74M
and earned -16.29M
in profits. Earnings per share was -2.02.
Revenue 9.74M Gross Profit -9.06M Operating Income -18.23M Net Income -16.29M EBITDA -18.23M EBIT -18.23M Earnings Per Share (EPS) -2.02
Full Income Statement Balance Sheet The company has 9M in cash and 0 in
debt, giving a net cash position of 9M.
Cash & Cash Equivalents 9M Total Debt n/a Net Cash n/a Retained Earnings -70.73M Total Assets 38.58M Working Capital 34.63M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -16.53M
and capital expenditures 0, giving a free cash flow of -16.53M.
Operating Cash Flow -16.53M Capital Expenditures n/a Free Cash Flow -16.53M FCF Per Share -2.05
Full Cash Flow Statement Margins Gross margin is -93.04%, with operating and profit margins of -187.17% and -167.29%.
Gross Margin -93.04% Operating Margin -187.17% Pretax Margin -167.29% Profit Margin -167.29% EBITDA Margin -187.17% EBIT Margin -187.17% FCF Margin -169.76%
Dividends & Yields CRVO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for CRVO is $15,
which is 57.4% higher than the current price. The consensus rating is "Strong Buy".
Price Target $15 Price Target Difference 57.4% Analyst Consensus Strong Buy Analyst Count 6
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 17, 2023. It was a
backward
split with a ratio of 2:3.
Last Split Date Aug 17, 2023 Split Type backward Split Ratio 2:3
Scores Altman Z-Score 9.1 Piotroski F-Score 2
